Have a personal or library account? Click to login
Usefulness of Presepsin (sCD14-ST) in diagnosis of Infective Endocarditis - preliminary results of an observational study / Utilitatea presepsinului (sCD14-ST) în Endocardita Infecțioasă –rezultate preliminare ale unui studiu observațional Cover

Usefulness of Presepsin (sCD14-ST) in diagnosis of Infective Endocarditis - preliminary results of an observational study / Utilitatea presepsinului (sCD14-ST) în Endocardita Infecțioasă –rezultate preliminare ale unui studiu observațional

Revista Romana de Medicina de Laborator
Volume 23 (2015): Issue 3 (August 2015)
By: Adriana Topan,  Dumitru Carstina,  Raluca Rancea,  Adriana Slavcovici,  Mirela Flonta and  Mihaela Lupse  
Open Access
|Sep 2015

References

  1. 1. Prendergast B. The changing face of infective endocarditis. Heart. 2006 Jul;92(7):879-85. DOI: 10.1136/ hrt.2005.06725610.1136/hrt.2005.067256186069816216860
    Search in Google Scholar
  2. 2. Li SJ, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000 Apr;30(4):633-38. DOI: 10.1086/31375310.1086/31375310770721
    Search in Google Scholar
  3. 3. Lamas CC, Eykyn SJ. Blood culture negative endocarditis : analysis of 63 cases presenting over 25 years. Heart. 2003 Mar;89(3):258-62. DOI: 10.1136/ heart.89.3.25810.1136/heart.89.3.258176757912591823
    Search in Google Scholar
  4. 4. Heiro M, Helenius H, Sundell J, Koskinen P, Engblom E, Nikoskelainen J, et al. Utility of serum C-reactive protein in assessing the outcome of infective endocarditis. Eur Heart J. 2005 Sep;26(18):1873-81. DOI: 10.1093/eurheartj/ehi27710.1093/eurheartj/ehi27715855194
    Search in Google Scholar
  5. 5. Gouriet F, Bothelo-Nevers E, Coulibaly B, Raoult D. Evaluation of sedimentation rate, rheumatoid factor, C-reactive protein and tumor necrosis factor for the diagnosis of infective endocarditis. Clin Vaccine Immunol. 2006 Feb;13(2):301. DOI: 10.1128/ CVI.13.2.301.200610.1128/CVI.13.2.301.2006139193816467342
    Search in Google Scholar
  6. 6. Simon L, Gauvin F, Amre DV, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004 Jul 15;39(2):206-17. DOI: 10.1086/42199710.1086/42199715307030
    Search in Google Scholar
  7. 7. Yu CW, Juan LI, Hsu SC, Chen CK, Wu CW, Lee CC, et al. Role of the procalcitonin in the diagnosis of infective endocarditis: a meta-analysis. Am J Emerg Med. 2013 Jun;31(6):935-41. DOI: 10.1016/j.ajem.2013.03.00810.1016/j.ajem.2013.03.00823601504
    Search in Google Scholar
  8. 8. Shozushima T, Takahashi G, Matsumoto N, Kojika M, Okamura Y, Endo S. Usefulness of presepsin (sCD14- ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J Infect Chemoter. 2011 Dec;17(6):764-69. DOI: 10.1007/s10156-011-0254-x10.1007/s10156-011-0254-x21560033
    Search in Google Scholar
  9. 9. Mallet-Coste T, Chenevier-Gobeaux C, Fissore-Magdelein C, Magdelein X, Brod F, Claessens YE. La présepsine (sCD14-ST), nouveau biomarquer de la réponse anti-infectieuse. Ann Fr Med Urgence. 2013 Sept;3(5):305-9. DOI: 10.1007/s13341-013-0347-510.1007/s13341-013-0347-5
    Search in Google Scholar
  10. 10. Okamura Y, Yokoi H. Development of a point-of-care assay system for measurement of presepsin (sCD14- ST). Clin Chim Acta. 2011 Nov;412(23-24):2157-61. DOI: 10.1016/j.cca.2011.07.02410.1016/j.cca.2011.07.02421839732
    Search in Google Scholar
  11. 11. Yaeghashi Y, Shirakawa K, Sato N, Suzuki Y, Kojika M, Imai S, et al. Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis. J Infect Chemoter. 2005;11(5):234-38. DOI: 10.1007/s10156-005-0400-410.1007/s10156-005-0400-416258819
    Search in Google Scholar
  12. 12. Romualdo LG, Torrella PE, González MV, Sánchez RJ, Hodalgo AH, Freire AO, et al. Diagnostic accuracy of presepsin (soluble CD14 subtype) for prediction of bacteremia in patients with systemic inflammatory response syndrome in the Emergency Departament. Clin Biochem. 2014 May;47(7):505-8. DOI: 10.1016/j.clinbiochem.2014.02.01110.1016/j.clinbiochem.2014.02.01124560955
    Search in Google Scholar
  13. 13. Endo S, Suzuki Y, Takahashi G, Shozushima T, Ishikura H, Murai A, et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemoter. 2012 Dec;18(6):891-97. DOI: 10.1007/ s10156-012-0435-210.1007/s10156-012-0435-222692596
    Search in Google Scholar
  14. 14. Werdan K, Dietz S, Löffler B, Niemann S, Bushnaq H, Silber RE, et al. Mechanisms of infective endocarditis: pathogen-host interaction and risk states. Nat Rev Cardiol. 2014;11(1):35-50. DOI: 10.1038/nrcardio.2013.17410.1038/nrcardio.2013.17424247105
    Search in Google Scholar
  15. 15. Christiansen JG, Jensen HE, Jensen LK, Koch J, Aalbaek B, Nielsen OL, et al. Systemic inflammatory response and local cytokine expression in porcine models of endocarditis. Acta Pathol Microbiol Immunol Scand. 2014 Apr;122(4):292-300. DOI: 10.1111/apm.1214510.1111/apm.1214523879680
    Search in Google Scholar
  16. 16. Habib G, Hoen B, Thornos P, Thuny F, Prendergast, Vilacosta I, et al. Guidelines of the prevention, diagnosis and treatment of infective endocarditis (new version 2009). The task force on the prevention, diagnosis and treatement of infective endocarditis of the European Society of Cardiology. Eur Heart J. 2009;30(19):2369-2413. DOI: 10.1093/eurheartj/ehp28510.1093/eurheartj/ehp28519713420
    Search in Google Scholar
  17. 17. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach O, Opal SM, et al. Surviving Sepsis Campaign Guidelines Committee including the Pediatric subgroup. Surviving Sepsis Campaign: International guidelines for the management of severe sepsis and septic shock:2012. Crit Care Med. 2013 Feb;41(2):580-637. DOI: 10.1097/CCM.0b013e31827e83af10.1097/CCM.0b013e31827e83af23353941
    Search in Google Scholar
  18. 18. Giavarina D, Carta M. Determination of reference interval for presepsin, an early marker for sepsis. Biochem Med. 2015;25(1):64-68. DOI: 10.11613/BM.2015.00710.11613/BM.2015.007440131025672468
    Search in Google Scholar
  19. 19. Ulla M, Pizzolato E, Lucchiari M, Loiacano M, Soardo F, Forno D, et al. Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study. Crit Care. 2013 Jul 20;17(4):R168. DOI: 10.1186/cc1284710.1186/cc12847405676223899120
    Search in Google Scholar
  20. 20. Chenevier-Gobeaux C, Trabattoni E, Roelens M, Borderie D, Claessens YE. Presepsin (sCD14-ST) in emergency department: the need for adapted threshold values? Clin Chim Acta. 2014 Jan 1;427:34-36. DOI: 10.1016/j.cca.2013.09.01910.1016/j.cca.2013.09.01924076253
    Search in Google Scholar
  21. 21. Behnes M, Bertsch T, Lepiorz D, Lang S, Trinkmann F, Brueckmann M, et al. Diagnostic and prognostic utility of soluble CD14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment. Crit Care. 2014;18(5):507. DOI: 10.1186/ s13054-014-0507-z10.1186/s13054-014-0507-z417428325190134
    Search in Google Scholar
  22. 22. Liu B, Yin Q, Chen YX, Zhao YZ, Li CS. Role of Presepsin (sCD14-ST) and the CURB65 scoring system in predicting severity and outcome of community- acquired pneumonia in an emergency department. Resp Med. 2014 Aug;108(8):1204-13. DOI: 10.1016/j. rmed.2014.05.005
    Search in Google Scholar
  23. 23. Zou Q, Wen W, Zhang X. Presepsin as a novel sepsis biomarker. World J Emerg Med. 2014;5(1):16-19. DOI: 10.5847/wjem.j.issn.1920-8642.2014.01.00210.5847/wjem.j.issn.1920-8642.2014.01.002412985725215141
    Search in Google Scholar
  24. 24. Murdoch DR, Corey GR, Hoen B, Miro J, Fowler VG, Bayer AS, et al. Clinical presentation, etiology and outcome of infective endocarditis in the 21st Century. Arch Intern Med. 2009 Mar 9; 169(5):463-473. DOI: 10.1001/archinternmed.2008.60310.1001/archinternmed.2008.603362565119273776
    Search in Google Scholar
  25. 25. Tariq M, Alam M, Munir G, Khan MA, Smego RA Jr. Infective endocarditis: a five - year experience at a tertiary care hospital in Pakistan. Int J Infect Dis. 2004 May;8(3):163-70. DOI: 10.1016/j.ijid.2004.02.00110.1016/j.ijid.2004.02.00115109591
    Search in Google Scholar
  26. 26. Kapla JM, Wrong HR. Biomarker discovery and the development in pediatric critical care medicine. Pediatr Crit Care Med. 2011;12(2):165-73. DOI: 10.1097/PCC.0b013e3181e28876 10.1097/PCC.0b013e3181e28876292446220473243
    Search in Google Scholar
DOI: https://doi.org/10.1515/rrlm-2015-0025 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Journal RSS Feed
Language: English
Page range: 303 - 311
Submitted on: Mar 12, 2015
Accepted on: Jun 26, 2015
Published on: Sep 30, 2015
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Presepsin,
infective endocarditis,
biomarker
Related subjects:
Life sciences,
Molecular biology,
Biochemistry,
Human biology,
Microbiology and virology

© 2015 Adriana Topan, Dumitru Carstina, Raluca Rancea, Adriana Slavcovici, Mirela Flonta, Mihaela Lupse, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 23 (2015): Issue 3 (August 2015)Next article